Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2002 Jul;57(7):569–574. doi: 10.1136/thorax.57.7.569

The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients

H Vally 1, M Taylor 1, P Thompson 1
PMCID: PMC1746373  PMID: 12096197

Abstract

Background: Aspirin intolerant asthma (AIA) is a clinically distinct syndrome characterised by the precipitation of asthma attacks following the ingestion of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs). The prevalence of AIA among Australian asthmatic patients has not previously been reported.

Methods: Three populations were surveyed to establish the prevalence of AIA among Australian asthmatics. Two surveys were completed in patients recruited from the metropolitan area in Perth, Western Australia, one comprising 150 recruited from hospital based sources (hospital cohort) and the second comprising 366 from the membership of the Asthma Foundation of Western Australia (Asthma Foundation cohort). In a third study 1298 individuals were randomly selected from the rural community of Busselton in Western Australia.

Results: The prevalence of AIA in the hospital and Asthma Foundation cohorts was found to be 10.7% and 10.4%, respectively. Univariate analyses in the Asthma Foundation cohort indicated that AIA was associated with more severe asthma (OR = 2.4, 95% CI 1.18 to 4.86), nasal polyposis (OR=3.19, 95% CI 1.52 to 6.68), atopy (OR=2.96, 95% CI 1.48 to 5.89), sulfite sensitivity (OR=3.97, 95% CI 1.87 to 8.41), and sensitivity to wine (OR=3.27, 95% CI 1.65 to 6.47). Multivariate analyses indicated that atopy (OR=2.80, 95% CI 1.38 to 5.70), nasal polyposis (OR=3.39, 95% CI 1.57 to 7.29), and the number of asthma attacks in the previous 12 months (OR=1.20, 95% CI 1.02 to 1.42) were independent predictors for AIA, as was wine sensitivity (OR=2.20, 95% CI 1.02 to 4.72). The prevalence of AIA among asthmatic patients in the Busselton cohort was 10.9%. In addition, 2.5% of non-diagnosed asthmatics in this cohort reported asthma symptoms following aspirin ingestion.

Conclusion: The prevalence of respiratory symptoms triggered by aspirin/NSAID use was found to be 10–11% in patients with asthma and 2.5% in non-asthmatics. Aspirin sensitivity appears to be a significant problem in the community and further investigations of the mechanisms of these responses and the possible link between this syndrome and other food and chemical sensitivities are required.

Full Text

The Full Text of this article is available as a PDF (153.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bochenek G., Nizankowska E., Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 1996 Jan;51(1):16–23. doi: 10.1111/j.1398-9995.1996.tb04544.x. [DOI] [PubMed] [Google Scholar]
  2. Delaney J. C. The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy. 1976 Mar;6(2):177–181. doi: 10.1111/j.1365-2222.1976.tb01896.x. [DOI] [PubMed] [Google Scholar]
  3. Falliers C. J. Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol. 1973 Sep;52(3):141–147. doi: 10.1016/0091-6749(73)90030-4. [DOI] [PubMed] [Google Scholar]
  4. Giraldo B., Blumenthal M. N., Spink W. W. Aspirin intolerance and asthma. A clinical and immunological study. Ann Intern Med. 1969 Sep;71(3):479–496. doi: 10.7326/0003-4819-71-3-479. [DOI] [PubMed] [Google Scholar]
  5. Hedman J., Kaprio J., Poussa T., Nieminen M. M. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999 Aug;28(4):717–722. doi: 10.1093/ije/28.4.717. [DOI] [PubMed] [Google Scholar]
  6. Kumlin M. Measurement of leukotrienes in humans. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S102–S106. doi: 10.1164/ajrccm.161.supplement_1.ltta-20. [DOI] [PubMed] [Google Scholar]
  7. Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy. 1998 Jun;28 (Suppl 2):3–10. [PubMed] [Google Scholar]
  8. Marquette C. H., Saulnier F., Leroy O., Wallaert B., Chopin C., Demarcq J. M., Durocher A., Tonnel A. B. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis. 1992 Jul;146(1):76–81. doi: 10.1164/ajrccm/146.1.76. [DOI] [PubMed] [Google Scholar]
  9. McDonald J. R., Mathison D. A., Stevenson D. D. Aspirin intolerance in asthma. Detection by oral challenge. J Allergy Clin Immunol. 1972 Oct;50(4):198–207. doi: 10.1016/0091-6749(72)90014-0. [DOI] [PubMed] [Google Scholar]
  10. Peat J. K., Haby M., Spijker J., Berry G., Woolcock A. J. Prevalence of asthma in adults in Busselton, Western Australia. BMJ. 1992 Nov 28;305(6865):1326–1329. doi: 10.1136/bmj.305.6865.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Perry C. A., Dwyer J., Gelfand J. A., Couris R. R., McCloskey W. W. Health effects of salicylates in foods and drugs. Nutr Rev. 1996 Aug;54(8):225–240. doi: 10.1111/j.1753-4887.1996.tb03940.x. [DOI] [PubMed] [Google Scholar]
  12. Picado C., Castillo J. A., Montserrat J. M., Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J. 1989 Feb;2(2):127–129. [PubMed] [Google Scholar]
  13. Rivas B. The management of ASA syndrome. J Investig Allergol Clin Immunol. 1997 Sep-Oct;7(5):392–396. [PubMed] [Google Scholar]
  14. Samter M., Beers R. F., Jr Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968 May;68(5):975–983. doi: 10.7326/0003-4819-68-5-975. [DOI] [PubMed] [Google Scholar]
  15. Settipane G. A., Chafee F. H., Klein D. E. Aspirin intolerance. II. A prospective study in an atopic and normal population. J Allergy Clin Immunol. 1974 Apr;53(4):200–204. doi: 10.1016/0091-6749(74)90081-5. [DOI] [PubMed] [Google Scholar]
  16. Simon R. A. Oral challenges to detect aspirin and sulfite sensitivity in asthma. Allerg Immunol (Paris) 1994 Jun;26(6):216–218. [PubMed] [Google Scholar]
  17. Spector S. L., Wangaard C. H., Farr R. S. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol. 1979 Dec;64(6 Pt 1):500–506. doi: 10.1016/0091-6749(79)90059-9. [DOI] [PubMed] [Google Scholar]
  18. Stevenson D. D. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol. 1984 Oct;74(4 Pt 2):617–622. doi: 10.1016/0091-6749(84)90115-5. [DOI] [PubMed] [Google Scholar]
  19. Szczeklik A., Nizankowska E., Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000 Sep;16(3):432–436. doi: 10.1034/j.1399-3003.2000.016003432.x. [DOI] [PubMed] [Google Scholar]
  20. Szczeklik A., Stevenson D. D. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999 Jul;104(1):5–13. doi: 10.1016/s0091-6749(99)70106-5. [DOI] [PubMed] [Google Scholar]
  21. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J. 1990 May;3(5):588–593. [PubMed] [Google Scholar]
  22. Toelle B. G., Peat J. K., Salome C. M., Mellis C. M., Woolcock A. J. Toward a definition of asthma for epidemiology. Am Rev Respir Dis. 1992 Sep;146(3):633–637. doi: 10.1164/ajrccm/146.3.633. [DOI] [PubMed] [Google Scholar]
  23. Vally H., de Klerk N., Thompson P. J. Asthma induced by alcoholic drinks: a new food allergy questionnaire. Aust N Z J Public Health. 1999 Dec;23(6):590–594. doi: 10.1111/j.1467-842x.1999.tb01542.x. [DOI] [PubMed] [Google Scholar]
  24. Yan K., Salome C., Woolcock A. J. Rapid method for measurement of bronchial responsiveness. Thorax. 1983 Oct;38(10):760–765. doi: 10.1136/thx.38.10.760. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES